Identification and Bioactivity Analysis of a Novel Bacillus Species, B. maqinnsis sp. nov. Bos-x6-28, Isolated from Feces of the Yak (Bos grunniens)
2024

New Bacillus Species from Yak Feces Shows Antibiotic and Antitumor Potential

Sample size: 1 publication 10 minutes Evidence: high

Author Information

Author(s): Ma Qiang, Xiang Xin, Ma Yan, Li Guangzhi, Liu Xingyu, Jia Boai, Yang Wenlin, Yin Hengxia, Zhang Benyin, Monteiro-Neto Valério, Fernandes Elizabeth S.

Primary Institution: Qinghai University

Hypothesis

The study aims to identify and analyze the bioactivity of a novel Bacillus species isolated from yak feces.

Conclusion

The novel Bacillus species B. maqinnsis Bos-x6-28 shows promise as a source for new antibiotics and antitumor agents.

Supporting Evidence

  • Strain Bos-x6-28 shares 98.91% similarity with known Bacillus species.
  • It can utilize various carbon and nitrogen sources.
  • Genomic analysis indicates potential for producing bioactive compounds.
  • Strain exhibits antibacterial activity against B. subtilis.
  • It shows cytotoxic effects on HepG2 cancer cells.

Takeaway

Scientists found a new type of bacteria in yak poop that can help make new medicines to fight infections and cancer.

Methodology

The study used polyphasic taxonomic analysis and bioactive assays to characterize the Bacillus strain Bos-x6-28.

Participant Demographics

The strain was isolated from feces of free-grazing yaks in high-altitude regions.

Digital Object Identifier (DOI)

10.3390/antibiotics13121238

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication